Professor Paul Reynolds trained at the University of Adelaide and the Royal Adelaide Hospital in General and Thoracic Medicine. He was admitted as a Fellow of the Royal Australasian College of Physicians in 1992. He completed a PhD in airway inflammation at the Hanson Institute then spent five years working in the USA at the University of Alabama at Birmingham Division of Human Gene Therapy. In 2002 he returned to the Royal Adelaide Hospital Department of Thoracic Medicine as Senior Consultant Physician and Director of the Lung Research Laboratory, Hanson Institute. In 2004 he completed post-FRACP accreditation in Sleep Medicine and in 2005 was appointed as Clinical Associate Professor in the Department of Medicine of the University of Adelaide and then promoted to Professor in 2010. He was awarded an MD for his Gene Therapy work in 2009.
In 2006 he was awarded a prestigious National Health and Medical Research Council Practitioner Fellowship, which was renewed in 2011. He has acquired numerous research grants from the NHMRC and other agencies relating to a broad range of respiratory conditions including COPD, Pulmonary Hypertension, Mesothelioma, Lung Cancer and Lung Transplantation.
More recently his research interests have expanded to include the role of atherogenic inflammatory mediators in Obstructive Sleep Apnoea and novel therapies for Interstitial Lung Disease. He has an extensive publication track record and frequently presents original basic and translational research in national and international conferences. He is also actively engaged in the conduct of Clinical Trials of new pharmaceutical agents and therapeutic devices.
Other roles have included President of the Thoracic Society of Australia and New Zealand (2011-12), Chairman of the Specialty Training Committee in Respiratory and Sleep Medicine of the Royal Australasian College of Physicians, Chairman of the Medical and Scientific Advisory Committee and Board Director / Vice President of the Asthma Foundation of SA, member of the Curriculum Development Committee for Respiratory Medicine of the RACP, Member of the National Reference Group for Lung Cancers. In 2007 Prof Reynolds was Convenor of the Joint Congress of the Asian Pacific Society of Respirology / American College of Chest Physicians Annual Scientific Congress. His clinical interests span the breadth of Respiratory and Sleep medicine and his research program is directed at the development of novel therapeutic strategies and clinical translation.